While the first coronavirus vaccine has received emergency use authorization from the FDA, the author of today’s article points out that “The coronavirus vaccine race isn’t over.” So which COVID […]
read more
Market History Suggests This “Breakthrough” ETF Is A Smart Post-Election Idea
Investors looking for a post-election idea may want to consider the ETF highlighted in today’s article, which tracks an index “comprised of small- and mid-cap stocks of biotechnology companies that […]
read more